Nationwide Fund Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-29,827
| Closed | -$231K | – | 1017 |
|
|
2017
Q3 | $231K | Sell |
29,827
-109,459
| -79% | -$848K | ﹤0.01% | 2569 |
|
|
2017
Q2 | $1.02M | Buy |
139,286
+107,190
| +334% | +$788K | ﹤0.01% | 1766 |
|
|
2017
Q1 | $239K | Sell |
32,096
-2,373
| -7% | -$17.7K | ﹤0.01% | 2505 |
|
|
2016
Q4 | $240K | Buy |
34,469
+1,660
| +5% | +$11.6K | ﹤0.01% | 2521 |
|
|
2016
Q3 | $270K | Buy |
32,809
+2,702
| +9% | +$22.2K | ﹤0.01% | 2482 |
|
|
2016
Q2 | $244K | Hold |
30,107
| – | – | ﹤0.01% | 2513 |
|
|
2016
Q1 | $153K | Hold |
30,107
| – | – | ﹤0.01% | 2649 |
|
|
2015
Q4 | $232K | Buy |
30,107
+1,085
| +4% | +$8.36K | ﹤0.01% | 2472 |
|
|
2015
Q3 | $167K | Hold |
29,022
| – | – | ﹤0.01% | 2659 |
|
|
2015
Q2 | $266K | Buy |
+29,022
| New | +$266K | ﹤0.01% | 2557 |
|